Novagold Resources Inc. vs Smith & Nephew plc — how do they compare? Novagold Resources Inc. trades at $6.32 (market cap $2.90B), while Smith & Nephew plc trades at $28.46 (market cap $11.60B). The key difference: Smith & Nephew plc is far larger — about 4× Novagold Resources Inc.'s market cap, and Smith & Nephew plc pays a 2.85% dividend while Novagold Resources Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Novagold Resources Inc. for 0 Days and Smith & Nephew plc for 121 Days on average.
| NG | SNN | |
|---|---|---|
Market Cap | $2.90B | $11.60B |
Volume | 3,973,464 | 971,836 |
Sector | Basic Materials | Health |
52-Week High | $14.20 | $37.17 |
52-Week Low | $5.18 | $26.42 |
Typical Hold Time | 0 Days | 121 Days |
Enterprise Value | $2.74B | $14.63B |
Dividend Yield | — | 2.85% |
Signals from Pluang's Aura AI — not financial advice
NovaGold Resources (NG) trades at $6.63, down 1.49% today, as the company navigates its development phase for the Donlin Gold project. The stock shows mixed earnings performance with recent quarterly losses but beats expectations in two of the last four quarters. Financials reveal negative profitability metrics with ROE at -32.81% and net income of -$94.66M for 2025, though cash flow remains positive due to financing activities. Recent news highlights the company's move to acquire full ownership of Donlin Gold, a major Alaska gold project.
The outlook for NG hinges on successful development of Donlin Gold, with 100% analyst buy ratings signaling strong Wall Street confidence. However, significant execution risks exist given negative earnings and substantial capital requirements. Investors face volatility from gold price fluctuations and project development timelines, making this suitable for those with high risk tolerance seeking exposure to a major gold development story.
SNN trades at $27.88, near its 52-week low, with a mixed technical signal but improving fundamentals. Revenue grew to $6.16B in 2025, with net income margin expanding to 10.08%. Recent product launches like the EVOS PELVIC System and FLOW FLEXTEND COBLATION Wand highlight innovation, though the stock faces bearish moving averages and neutral oscillators.
Outlook is cautious; strong profitability and cash flow support value, but analyst consensus is predominantly Hold amid competitive pressures and recent CFO departure. Risks include execution challenges and debt levels, yet institutional interest from BlackRock's $505M investment signals confidence. The stock offers potential for recovery if operational targets are met.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
NovaGold Resources Inc. is a mineral exploration and development company that holds a majority interest in the Donlin Gold project, an undeveloped gold deposit in Alaska.
Read more on NG →Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →